Literature DB >> 35690699

MS diagnosis in a male patient with m.11778G > A Leber's hereditary optic neuropathy.

Pasquale Scoppettuolo1, Cecile Retif2, Stelianos Kampouridis3, Audrey Meunier4, Joachim Schulz2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35690699     DOI： 10.1007/s10072-022-06193-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.830


× No keyword cloud information.
  5 in total

1.  Occurrence of a multiple sclerosis-like illness in women who have a Leber's hereditary optic neuropathy mitochondrial DNA mutation.

Authors:  A E Harding; M G Sweeney; D H Miller; C J Mumford; H Kellar-Wood; D Menard; W I McDonald; D A Compston
Journal:  Brain       Date:  1992-08       Impact factor: 13.501

Review 2.  Late-onset Leber's hereditary optic neuropathy presenting with longitudinally extensive myelitis harbouring the m.14484T>C mutation: Extending the genotype-phenotype spectrum.

Authors:  Jonathan Cleaver; Hamish Morrison; Gavin Reynolds; Richard James; Jacqueline Palace; Gurjit Chohan
Journal:  Mult Scler Relat Disord       Date:  2020-12-15       Impact factor: 4.339

Review 3.  Multiple sclerosis associated with Leber's Hereditary Optic Neuropathy.

Authors:  Jacqueline Palace
Journal:  J Neurol Sci       Date:  2009-10-01       Impact factor: 3.181

4.  Leber's "plus": neurological abnormalities in patients with Leber's hereditary optic neuropathy.

Authors:  E K Nikoskelainen; R J Marttila; K Huoponen; V Juvonen; T Lamminen; P Sonninen; M L Savontaus
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-08       Impact factor: 10.154

5.  MRI in Leber's hereditary optic neuropathy: the relationship to multiple sclerosis.

Authors:  Lucy Matthews; Christian Enzinger; Franz Fazekas; Alex Rovira; Olga Ciccarelli; Maria Teresa Dotti; Massimo Filippi; Jette L Frederiksen; Antonio Giorgio; Wilhelm Küker; Carsten Lukas; Maria A Rocca; Nicola De Stefano; Ahmed Toosy; Tarek Yousry; Jacqueline Palace
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-07-22       Impact factor: 10.154
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.